Information is a patient’s greatest ally, but it’s no help if they can’t understand it.
NCPA's New Consortium Exemplifies Preparedness in Community Pharmacy
The new initiative is a way for NCPA to proactively engage its network of community pharmacies during a potential public health crisis.
American Pharmacies: Powering the Profession Through Leadership
Drug Topics sat down with Laird Leavoy, President of American Pharmacies, to discuss the role leadership plays in the independent pharmacy industry.
Nonopioid Therapy Shown to Significantly Reduce Pain Intensity in Phase 3 Trial
Cebranopadol is a first-in-class investigational therapy that targets the nociceptin/orphanin FQ receptor and the µ-opioid receptor.
How Centralized Fulfillment is Making Pharmacy More Efficient
Tom Utech, PharmD, CEO of iA, joined Drug Topics to discuss his company’s centralized pharmacy fulfillment solutions.
Q&A: Ultra-High-Cost Drugs Highlight Complex US Health Care System
Erin Fox, PharmD, MHA, BCPS, FASHP, discussed the 2025 Pharmacy Forecast and its perspective on managing ultra-high-cost drugs.
Q&A: NCPA Announces Independent Community Pharmacy Consortium for Government Engagement
Kurt Proctor, PhD, RPh, President of the NCPA Innovation Center, discussed his organization’s efforts in launching the Independent Community Pharmacy Consortium for Government Engagement.